Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) appears in 232 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 401,951 | 5.30% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 106,277 | 0.75% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 333,701 | 16.66% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -205,271 | -52.51% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -34,625 | -0.38% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | -340,000 | -13.33% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 5,200 | 125.06% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | -344,102 | -4.11% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 95,038 | 6.49% | $0.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -4,607,098 | -39.92% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | -180,975 | -10.72% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -93,873 | -1.45% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 500,470 | 122.75% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 581,900 | 15.08% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 334,584 | 98.42% | $0.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 370,368 | 149.12% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -36,199 | -1.59% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -22,288 | -4.09% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -46,329 | -2.10% | $0.00 |